Back to Journals » Drug Design, Development and Therapy » Volume 8

Risk factors associated with ineligibility of adjuvant cisplatin-based chemotherapy after nephroureterectomy

Total article views   HTML views PDF downloads Totals
14,109 Dovepress* 13,624+ 1,094 14,718
PubMed Central* 485 174 659
Totals 14,109 1,268 15,377
*Since 21 October 2014
+Since July 2016

View citations on PubMed Central and Google Scholar